Finance

Lists
Why is CNBX up 33,33%?
Dive Deeper
CNBX:OTCMKTS
CNBX Pharmaceuticals Inc
0,00020 $
+33,33%
(+0,000050) 1D
19 қаз., 09:30:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNBX...
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
444,80
Avg. vol.
6,28 млн
Volume
3,52 мың
52-wk high
0,00 $
52-wk low
0,00 $
EPS
-0,00 $
Beta
-2,39
Shares outstanding
1,61 млрд
No. of employees
1
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
444,80
Avg. vol.
6,28 млн
Volume
3,52 мың
52-wk high
0,00 $
52-wk low
0,00 $
EPS
-0,00 $
Beta
-2,39
Shares outstanding
1,61 млрд
No. of employees
1
News stories
From web sources and news partners
About CNBX Pharmaceuticals Inc
CEO-
Employees1
Founded2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. там.
2025 ж. қар.
2026 ж. ақп.
2026 ж. мам.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
129,73 м.
64,00 мың
72,96 мың
162,76 м.
Operating expense
129,73 м.
64,00 мың
72,96 мың
162,76 м.
Total operating expenses
129,73 м.
64,00 мың
72,96 мың
162,76 м.
Operating income
-129,73 м.
-64,00 мың
-72,96 мың
-162,76 м.
Other non operating income
-
-
-
-
EBT including unusual items
-150,11 м.
-113,72 м.
-44,10 мың
-154,16 м.
EBT excluding unusual items
-150,11 м.
-113,72 м.
-44,10 мың
-154,16 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-150,11 м.
-113,72 м.
-44,10 мың
-154,16 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
28,86 мың
8,60 мың
Interest expense
-18,28 мың
-49,72 мың
-
-
Net interest expenses
-18,28 мың
-49,72 мың
28,86 мың
8,60 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-111,65 м.
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары